CTCF and central nervous system cancer: Another naturally-occurring example of this was recently shown in the context of brain cancer, where hypermethylation at particular CTCF sites in low-grade IDH1-mutant gliomas leads to differential CTCF binding, changes in genome topology, and consequent dysregulation of proto-oncogenes [121].